In order to determine how the application of PD168393 impacts cellular immune responses following vaccination, we measured influenza-specific IgM+ and IgG+-secreting plasma cells in the skin draining lymph nodes and the spleen at one and two weeks post-vaccination. This evidence concerns the gene CD40LG and influenza.